Stocks and Investing
Stocks and Investing
Fri, August 6, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 5, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Stringer Maintained (ACAD) at Strong Buy with Decreased Target to $26 on, Aug 5th, 2021
Joseph Stringer of Needham, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Decreased Target from $30 to $26 on, Aug 5th, 2021.
Joseph has made no other calls on ACAD in the last 4 months.
There are 6 other peers that have a rating on ACAD. Out of the 6 peers that are also analyzing ACAD, all agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Esther Hong of "Berenberg" Initiated at Hold and Held Target at $29 on, Thursday, June 10th, 2021
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $27 on, Wednesday, May 12th, 2021
- Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold and Decreased Target to $18 on, Wednesday, April 7th, 2021
- Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $21 on, Tuesday, April 6th, 2021
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Tuesday, April 6th, 2021
- Vamil Divan of "Mizuho" Downgraded from Strong Buy to Hold and Held Target at $25 on, Tuesday, April 6th, 2021
Contributing Sources